Want to join the conversation?
$IRM said it is working closely with the ACCC to address the issues raised and is committed to making any divestments required to obtain the competition approvals in Australia, without any monetary cap. The ACCC has indicated that it expects to announce its final decision in respect of the transaction on December 15, 2015.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.